Trial Profile
A Double-Blind, Randomized, Placebo Controlled Intervention Study to Assess the Impact of Sitagliptin 100 mg/Day for 1 Year on Insulin Independence Following Pancreatectomy and Autoislet Transplantation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Hyperglycaemia
- Focus Therapeutic Use
- 28 Sep 2016 Status changed from active, no longer recruiting to completed according to results published in the American Journal of Transplantation.
- 29 Feb 2016 Planned End Date changed from 1 Jan 2016 to 1 Jun 2016, as reported by ClinicalTrials.gov record.
- 09 Dec 2015 Planned End Date changed from 1 Sep 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov record.